Erdem-Eraslan, L., Gravendeel, L. A., de Rooi, J., Eilers, P. H., Idbaih, A., Spliet, W. G., . . . French, P. J. (2013). Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951. American Society of Clinical Oncology.
Chicago Style CitationErdem-Eraslan, Lale, et al. Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951. American Society of Clinical Oncology, 2013.
Cita MLAErdem-Eraslan, Lale, et al. Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951. American Society of Clinical Oncology, 2013.